Effects of artesunate, dihydroartemisinin, and an artesunate-dihydroartemisinin combination against Toxoplasma gondii

Am J Trop Med Hyg. 2000 Jan;62(1):73-6. doi: 10.4269/ajtmh.2000.62.73.

Abstract

The effect of artesunate and its metabolite dihydroartemisinin against the cerebral cysts of Toxoplasma gondii was studied. In vitro experiments were performed with the THP-1 cell line and showed an inhibition of parasite growth of approximately 70% with 0.1-0.5 microg/ml of dihydroartemisinin for 96 hr. However, with artesunate, dihydroartemisinin, or a combination (50:50) of them, the number of tachyzoites decreased approximately 40-50% and they appeared motionless. Fifty-eight to 72 hr after washing of the tachyzoites and THP-1 cells in culture, parasitized cells reappeared. In vivo, the 50:50 artesunate-dihydroartemisinin combination produced a decrease in cerebral cysts of approximately 40% after only 5 days of treatment. However, transplantations into naive mice using brains of treated mice gave positive results.

MeSH terms

  • Animals
  • Antimalarials / pharmacology
  • Antimalarials / therapeutic use*
  • Artemisinins*
  • Artesunate
  • Brain / parasitology
  • Brain / pathology
  • Cell Line
  • Cell Survival / drug effects
  • Drug Combinations
  • Female
  • Histocytochemistry
  • Humans
  • Mice
  • Sesquiterpenes / pharmacology
  • Sesquiterpenes / therapeutic use*
  • Toxoplasma / drug effects*
  • Toxoplasmosis, Animal / drug therapy*
  • Toxoplasmosis, Animal / pathology

Substances

  • Antimalarials
  • Artemisinins
  • Drug Combinations
  • Sesquiterpenes
  • Artesunate
  • artenimol